Evidence map›Paper›PMID 31080813›Full record

ArticleBioMed research international2019

The Effects of Oral Isotretinoin in Women with Acne and Polycystic Ovary Syndrome.

G Acmaz, L Cınar, B Acmaz, H Aksoy, Yusuf Taner Kafadar, Y Madendag, F Ozdemir, E Sahin, I Muderris

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02855138 (The Effects of Oral Isotretinoin in Women With Acne and Polycystic Ovary Syndrome), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02855138 phase4completednot on this map

The Effects of Oral Isotretinoin in Women With Acne and Polycystic Ovary Syndrome

TypeinterventionalSponsorKayseri Education and Research HospitalRan2015 to 2016Enrolled80ConditionsAdverse Effects of Medical DrugsArmsoral isotretinoin
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Study of association between serum anti-Müllerian hormone, glucose intolerance, and metabolic syndrome in women with polycystic ovarian syndrome: A comparative study.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

G AcmazErciyes University Hospital, Department of Obstetrics and Gynecology, Kayseri, Turkey.ORCID 0000-0002-4215-3676
L CınarErciyes University School of Medicine, Department of Dermatology, Kayseri, Turkey.
B AcmazKayseri Education and Research Hospital of Medicine, Department of Internal Medicine, Kayseri, Turkey.
H AksoyKayseri Education and Research Hospital of Medicine, Department of Obstetrics and Gynecology, Turkey.
Yusuf Taner KafadarAnamur Government Hospital, Department of Obstetrics and Gynecology, Mersin, Turkey.
Y MadendagErciyes University Hospital, Department of Obstetrics and Gynecology, Kayseri, Turkey.ORCID 0000-0002-7622-2991
F OzdemirErciyes University Hospital, Department of Obstetrics and Gynecology, Kayseri, Turkey.
E SahinSivas Sarkısla Government Hospital, Department of Obstetrics and Gynecology, Sivas, Turkey.
I MuderrisErciyes University Hospital, Department of Obstetrics and Gynecology, Kayseri, Turkey.
Erciyes University · TRKayseri Eğitim ve Araştırma Hastanesi · TRSivas State Hospital · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMany patients who were diagnosed as polycystic ovary syndrome- (PCOS-) related acne were not capable of sustaining or beginning oral contraceptive pills (OCPs) due to pill scaring, contraindications of OCP use, migraine, or smoking. In this situation, oral isotretinoin treatment may become an important option for PCOS-related acne. The aim of the study was to determine the effects of isotretinoin treatment on PCOS patients who were complicated with severe cystic acne. MATERIALS AND

methodsThis study consisted of 40 female patients diagnosed as PCOS complicated with severe cystic acne. These patients were not eligible candidates for OCP use due to migraine, thrombophilia, heavy smoking, or pill scare. To establish baseline values of hormone levels, on days 2-5 of the menstrual cycle, venous blood samples were obtained. Moreover Modified Ferriman-Gallwey (mFG) score, acne score (AS), follicle count, and bilateral ovarian volumes were evaluated both before and after isotretinoin treatment.

resultsIsotretinoin treatment significantly decreased Ferriman-Gallwey score, free testosterone, insulin level, hemoglobin level, acne score, and ovarian volume. Increased triglyceride and cholesterol levels were detected after treatment.

conclusionIsotretinoin treatment may have beneficial effects on free testosterone, insulin, acne score, and Ferriman-Gallwey score. Solely isotretinoin administration may supply adequate healing in PCOS patients' symptoms complicated with severe cystic acne who is not eligible candidates for OCP use. This trial is registered with Clinicaltrials.gov NCT02855138.

Indexed as

Acne VulgarisAdolescentAdultContraceptives, Oral, CombinedFemaleHumansHyperandrogenismInsulinIsotretinoinMenstrual CyclePolycystic Ovary SyndromeProspective StudiesTestosteroneYoung AdultContraceptives, Oral, CombinedInsulinIsotretinoinTestosterone

Identifiers

PMID31080813
PMCPMC6475563
OpenAlexW2926804536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.